Your browser doesn't support javascript.
loading
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.
Seto, Anita G; Beatty, Xuan; Lynch, Joshua M; Hermreck, Melanie; Tetzlaff, Michael; Duvic, Madeleine; Jackson, Aimee L.
Affiliation
  • Seto AG; miRagen Therapeutics, Inc., Boulder, CO, USA.
  • Beatty X; miRagen Therapeutics, Inc., Boulder, CO, USA.
  • Lynch JM; miRagen Therapeutics, Inc., Boulder, CO, USA.
  • Hermreck M; miRagen Therapeutics, Inc., Boulder, CO, USA.
  • Tetzlaff M; Section of Dermatopathology, Department of Pathology, Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Duvic M; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jackson AL; miRagen Therapeutics, Inc., Boulder, CO, USA.
Br J Haematol ; 183(3): 428-444, 2018 11.
Article in En | MEDLINE | ID: mdl-30125933

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides / RNA, Neoplasm / Human T-lymphotropic virus 1 / HTLV-I Infections / Lymphoma, T-Cell, Cutaneous / MicroRNAs Limits: Female / Humans / Male Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides / RNA, Neoplasm / Human T-lymphotropic virus 1 / HTLV-I Infections / Lymphoma, T-Cell, Cutaneous / MicroRNAs Limits: Female / Humans / Male Language: En Journal: Br J Haematol Year: 2018 Type: Article Affiliation country: United States